| Kode Mata Kuliah | FA4032 / 2 SKS |
|---|
| Penyelenggara | 107 - Pharmaceutical Science and Technology / SF |
|---|
| Kategori | Lecture |
|---|
| Bahasa Indonesia | English |
|---|
| Nama Mata Kuliah | Terapi Rekombinan Mendatang | Future Recombinant Therapy |
|---|
| Bahan Kajian | - Produk terapi aptamer, anti-sense, terapi gen
- Produk antibodi monoklonal
- Produk vaksin berbasis asam nukleat
- Produk berbasis CRISPR-Cas
- Formulasi dan sistem penghantaran asam nukleat
| - Aptamer, anti-sense, and gene therapy based product
- Monoclonal antibody products
- Nucleic acid-based vaccine products
- CRISPR-Cas based products
- Nucleic acid formulation and delivery system
|
|---|
| Capaian Pembelajaran Mata Kuliah (CPMK) | - Mampu menjelaskan mekanisme kerja produk terapi advanced dan vaksin non-konvensional
- Mampu menjelaskan karakteristik produk terapi advanced dan vaksin non-konvensional
| - Able to explain the mechanism of action of advanced therapeutic products and non-conventional vaccines
- Able to explain the characteristics of advanced therapeutic products and non-conventional vaccines
|
|---|
| Metode Pembelajaran | Kuliah, diskusi, penugasan mandiri | Lecture, discussion, Assignment |
|---|
| Modalitas Pembelajaran | Visual dan auditorial yang dilaksanakan secara sinkron. | Visual, auditorial; synchronous |
|---|
| Jenis Nilai | ABCDE |
|---|
| Metode Penilaian | UTS, UAS, Tugas Presentasi | Mid exam, final exam, presentation |
|---|
| Catatan Tambahan | | |
|---|